Demand for MR scanners slumps in 2007

Article

Despite expanding clinical applications driven by functional and breast imaging, MR scanners are stuck in a sales doldrums.

Despite expanding clinical applications driven by functional and breast imaging, MR scanners are stuck in a sales doldrums.

Vendors last year sold about 850 new units to customers in the U.S., about 7% less than the year before. Their sale produced $1.3 billion in revenue, about 4% less than in 2006.

Sales turned up in the fourth quarter last year, according to GE Healthcare, a trend that the company, which dominates U.S. sales of MR scanners, said appears to be continuing. GE execs and some others in the industry are optimistic that this year will be better than last - but only fractionally so. Lingering reimbursement shortfalls, particularly in the outpatient sector, and macroeconomic fears of a recession have damped interest in buying new systems.

The situation may be worse, however, than some suspect. A Toshiba exec believes vendors may have pushed up delivery dates late last year, diminishing their backlogs to shore up year-end results.

Regardless of the reasons, the industry's workhorse 1.5T systems last year accounted for more than 70% of the revenue obtained from new unit sales in the U.S. The 630 such units reported by industry sources as being shipped to U.S. sites was virtually the same number sold in 2006, producing flat revenue year over year.

Demand for 3T edged up slightly last year, accounting for about $270 million in sales, an increase of about 4% over 2006. There is general consensus that demand for these systems will continue unabated in the months ahead.

Open systems were the Achilles' heel of the MR market last year. Sales reported by the big four vendors and Hitachi indicate a nearly 50% drop in demand for this once very popular type of product. Open MR sales reached just $65 million in 2007 compared to about $120 million the year before.

Recent Videos
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
Related Content
© 2025 MJH Life Sciences

All rights reserved.